Dried blood spot technique for the monitoring of ambrisentan, bosentan, sildenafil, and tadalafil in patients with pulmonary arterial hypertension

Endothelin receptor antagonists (ERA) and phosphodiesterase 5 inhibitors (PDE5I) are long-term therapeutics for the treatment of pulmonary arterial hypertension (PAH). Their interindividual pharmacokinetic variability is remarkably large, and despite the seriousness of the disease, nonadherence is o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Enderle, Yeliz (VerfasserIn) , Meid, Andreas (VerfasserIn) , Friedrich, Jörg (VerfasserIn) , Grünig, Ekkehard (VerfasserIn) , Wilkens, Heinrike (VerfasserIn) , Haefeli, Walter E. (VerfasserIn) , Burhenne, Jürgen (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: November 19, 2015
In: Analytical chemistry
Year: 2015, Jahrgang: 87, Heft: 24, Pages: 12112-12120
ISSN:1520-6882
DOI:10.1021/acs.analchem.5b03077
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1021/acs.analchem.5b03077
Volltext
Verfasserangaben:Yeliz Enderle, Andreas D. Meid, Jörg Friedrich, Ekkehard Grünig, Heinrike Wilkens, Walter E. Haefeli, and Jürgen Burhenne

MARC

LEADER 00000caa a2200000 c 4500
001 1724468677
003 DE-627
005 20230427070013.0
007 cr uuu---uuuuu
008 200713s2015 xx |||||o 00| ||eng c
024 7 |a 10.1021/acs.analchem.5b03077  |2 doi 
035 |a (DE-627)1724468677 
035 |a (DE-599)KXP1724468677 
035 |a (OCoLC)1341345191 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Enderle, Yeliz  |d 1983-  |e VerfasserIn  |0 (DE-588)1062693620  |0 (DE-627)805634339  |0 (DE-576)420014217  |4 aut 
245 1 0 |a Dried blood spot technique for the monitoring of ambrisentan, bosentan, sildenafil, and tadalafil in patients with pulmonary arterial hypertension  |c Yeliz Enderle, Andreas D. Meid, Jörg Friedrich, Ekkehard Grünig, Heinrike Wilkens, Walter E. Haefeli, and Jürgen Burhenne 
264 1 |c November 19, 2015 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 13.07.2020 
520 |a Endothelin receptor antagonists (ERA) and phosphodiesterase 5 inhibitors (PDE5I) are long-term therapeutics for the treatment of pulmonary arterial hypertension (PAH). Their interindividual pharmacokinetic variability is remarkably large, and despite the seriousness of the disease, nonadherence is occurring. Therefore, methods to monitor sufficient circulating drug levels are essential. The objectives of this study were to develop and validate dried blood spot (DBS) assays for the quantification of ambrisentan, bosentan, sildenafil, tadalafil, and their main metabolites. We also quantified the influence of different hematocrit levels and assessed the correlation of simultaneously taken capillary whole blood (DBS) and venous plasma samples. The aliquot punches were extracted by liquid/liquid extraction followed by liquid chromatography/tandem mass spectrometry (LC/MS/MS) quantification methods. All assays fulfilled the requirements of the FDA and EMA guidelines for assay validation with a lower limit of quantification of 2.5 ng/mL for the ERAs, 5 ng/mL for sildenafil, and 10 ng/mL for tadalafil. All analytes were stable for at least 147 days when stored on DBS filter paper cards at room temperature in the dark. Due to poor distribution into erythrocytes, drug concentrations in DBS were always lower than in plasma, resulting in conversion factors of 1.58 for ambrisentan and sildenafil and 1.52 for bosentan and tadalafil. 
700 1 |a Meid, Andreas  |d 1981-  |e VerfasserIn  |0 (DE-588)1076301991  |0 (DE-627)834660377  |0 (DE-576)445184582  |4 aut 
700 1 |a Friedrich, Jörg  |e VerfasserIn  |0 (DE-588)1144989574  |0 (DE-627)1005457506  |0 (DE-576)495576700  |4 aut 
700 1 |a Grünig, Ekkehard  |e VerfasserIn  |0 (DE-588)112535801  |0 (DE-627)618892605  |0 (DE-576)31856694X  |4 aut 
700 1 |a Wilkens, Heinrike  |e VerfasserIn  |4 aut 
700 1 |a Haefeli, Walter E.  |d 1958-  |e VerfasserIn  |0 (DE-588)124572359  |0 (DE-627)656806141  |0 (DE-576)340514221  |4 aut 
700 1 |a Burhenne, Jürgen  |d 1963-  |e VerfasserIn  |0 (DE-588)1034228889  |0 (DE-627)745126987  |0 (DE-576)381858197  |4 aut 
773 0 8 |i Enthalten in  |t Analytical chemistry  |d Columbus, Ohio : American Chemical Society, 1947  |g 87(2015), 24, Seite 12112-12120  |h Online-Ressource  |w (DE-627)300896530  |w (DE-600)1483443-1  |w (DE-576)088704564  |x 1520-6882  |7 nnas  |a Dried blood spot technique for the monitoring of ambrisentan, bosentan, sildenafil, and tadalafil in patients with pulmonary arterial hypertension 
773 1 8 |g volume:87  |g year:2015  |g number:24  |g pages:12112-12120  |g extent:9  |a Dried blood spot technique for the monitoring of ambrisentan, bosentan, sildenafil, and tadalafil in patients with pulmonary arterial hypertension 
856 4 0 |u https://doi.org/10.1021/acs.analchem.5b03077  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200713 
993 |a Article 
994 |a 2015 
998 |g 1034228889  |a Burhenne, Jürgen  |m 1034228889:Burhenne, Jürgen  |d 910000  |d 910100  |e 910000PB1034228889  |e 910100PB1034228889  |k 0/910000/  |k 1/910000/910100/  |p 7  |y j 
998 |g 124572359  |a Haefeli, Walter E.  |m 124572359:Haefeli, Walter E.  |d 910000  |d 910100  |e 910000PH124572359  |e 910100PH124572359  |k 0/910000/  |k 1/910000/910100/  |p 6 
998 |g 112535801  |a Grünig, Ekkehard  |m 112535801:Grünig, Ekkehard  |d 910000  |d 950000  |d 950900  |e 910000PG112535801  |e 950000PG112535801  |e 950900PG112535801  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |p 4 
998 |g 1144989574  |a Friedrich, Jörg  |m 1144989574:Friedrich, Jörg  |d 910000  |d 910100  |e 910000PF1144989574  |e 910100PF1144989574  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 1076301991  |a Meid, Andreas  |m 1076301991:Meid, Andreas  |d 910000  |d 910100  |e 910000PM1076301991  |e 910100PM1076301991  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 1062693620  |a Enderle, Yeliz  |m 1062693620:Enderle, Yeliz  |d 910000  |d 910100  |e 910000PE1062693620  |e 910100PE1062693620  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1724468677  |e 372392378X 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"role":"aut","given":"Yeliz","display":"Enderle, Yeliz","family":"Enderle"},{"role":"aut","display":"Meid, Andreas","family":"Meid","given":"Andreas"},{"given":"Jörg","display":"Friedrich, Jörg","family":"Friedrich","role":"aut"},{"role":"aut","display":"Grünig, Ekkehard","family":"Grünig","given":"Ekkehard"},{"given":"Heinrike","family":"Wilkens","display":"Wilkens, Heinrike","role":"aut"},{"role":"aut","family":"Haefeli","display":"Haefeli, Walter E.","given":"Walter E."},{"given":"Jürgen","display":"Burhenne, Jürgen","family":"Burhenne","role":"aut"}],"title":[{"title_sort":"Dried blood spot technique for the monitoring of ambrisentan, bosentan, sildenafil, and tadalafil in patients with pulmonary arterial hypertension","title":"Dried blood spot technique for the monitoring of ambrisentan, bosentan, sildenafil, and tadalafil in patients with pulmonary arterial hypertension"}],"physDesc":[{"extent":"9 S."}],"relHost":[{"disp":"Dried blood spot technique for the monitoring of ambrisentan, bosentan, sildenafil, and tadalafil in patients with pulmonary arterial hypertensionAnalytical chemistry","note":["Gesehen am 27.08.2020","Ungezählte Beil.: News & features"],"pubHistory":["19.1947 -"],"recId":"300896530","name":{"displayForm":["American Chemical Society"]},"origin":[{"publisher":"American Chemical Society","dateIssuedKey":"1947","publisherPlace":"Columbus, Ohio","dateIssuedDisp":"1947-"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"id":{"issn":["1520-6882"],"zdb":["1483443-1"],"eki":["300896530"]},"language":["eng"],"part":{"volume":"87","pages":"12112-12120","text":"87(2015), 24, Seite 12112-12120","year":"2015","extent":"9","issue":"24"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"subtitle":"the authoritative voice of the analytical community","title":"Analytical chemistry","title_sort":"Analytical chemistry"}]}],"language":["eng"],"id":{"doi":["10.1021/acs.analchem.5b03077"],"eki":["1724468677"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"November 19, 2015"}],"name":{"displayForm":["Yeliz Enderle, Andreas D. Meid, Jörg Friedrich, Ekkehard Grünig, Heinrike Wilkens, Walter E. Haefeli, and Jürgen Burhenne"]},"note":["Gesehen am 13.07.2020"],"recId":"1724468677"} 
SRT |a ENDERLEYELDRIEDBLOOD1920